{"id":"W2337880004","doi":"10.1093/neuonc/nov206.09","title":"ATCT-09IDH1 R132H MUTATIONS IN NRG ONCOLOGY/RTOG 9802: PHASE III STUDY OF RADIATION THERAPY (RT) ALONE VS RT PLUS PROCARBAZINE, CCNU, AND VINCRISTINE (PCV) IN PATIENTS WITH LOW GRADE GLIOMA (LGG)","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Cancer Care Ontario; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Procarbazine; Medicine; Oncology; Lomustine; Vincristine; Internal medicine; Radiation therapy; Glioma; Cancer research; Chemotherapy; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001436574,0.001064239,0.001484057,0.0004516283,0.0002233914,0.0006271746,0.001017846,0.0008373472,0.002473571],"category_scores_gemma":[0.0008176121,0.0004378872,0.0008872358,0.0005793019,0.0007969635,0.000407836,0.0002342071,0.001646608,0.0006729003],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001163449,"about_ca_system_score_gemma":0.001164234,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002017874,"about_ca_topic_score_gemma":0.006021632,"domain_scores_codex":[0.999622,0.0001998415,0.00002030495,0.00006009969,0.00004644162,0.00005125844],"domain_scores_gemma":[0.999406,0.0001025094,0.0001361483,0.00005304161,0.00002595639,0.0002763445],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7837156,0.03986415,0.01238915,0.0007729935,0.00144264,0.0002453724,0.0002921284,0.003173889,0.04027219,0.0002382588,0.002970114,0.1146236],"study_design_scores_gemma":[0.5184648,0.4505224,0.02212105,0.00005234698,0.0008449647,0.0005232674,0.00006933419,0.001729962,0.003542982,0.0001723927,0.001927106,0.00002937203],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961958,0.001223197,0.0001780075,0.0001898188,0.00005829796,0.0007156293,0.0004708871,0.000044234,0.0009241418],"genre_scores_gemma":[0.9935831,0.001306059,0.001071156,0.0003361296,0.0001095297,0.0008946738,0.00124187,0.0000251476,0.001432261],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002473571,"threshold_uncertainty_score":0.008441508,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03359925267274657,"score_gpt":0.358747573814432,"score_spread":0.3251483211416854,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}